Molecular insight on the non-covalent interactions between carbapenems and L,D-transpeptidase 2 from Mycobacterium tuberculosis: ONIOM study

Journal of Computer-aided Molecular Design
Thandokuhle NtombelaBahareh Honarparvar

Abstract

Tuberculosis remains a dreadful disease that has claimed many human lives worldwide and elimination of the causative agent Mycobacterium tuberculosis also remains elusive. Multidrug-resistant TB is rapidly increasing worldwide; therefore, there is an urgent need for improving the current antibiotics and novel drug targets to successfully curb the TB burden. L,D-Transpeptidase 2 is an essential protein in Mtb that is responsible for virulence and growth during the chronic stage of the disease. Both D,D- and L,D-transpeptidases are inhibited concurrently to eradicate the bacterium. It was recently discovered that classic penicillins only inhibit D,D-transpeptidases, while L,D-transpeptidases are blocked by carbapenems. This has contributed to drug resistance and persistence of tuberculosis. Herein, a hybrid two-layered ONIOM (B3LYP/6-31G+(d): AMBER) model was used to extensively investigate the binding interactions of LdtMt2 complexed with four carbapenems (biapenem, imipenem, meropenem, and tebipenem) to ascertain molecular insight of the drug-enzyme complexation event. In the studied complexes, the carbapenems together with catalytic triad active site residues of LdtMt2 (His187, Ser188 and Cys205) were treated at with QM [B3LYP...Continue Reading

References

Apr 30, 2004·Journal of Computational Chemistry·Junmei WangDavid A Case
Nov 9, 2007·Journal of Computer-aided Molecular Design·Fang Zheng, Chang-Guo Zhan
Apr 29, 2009·Methods : a Companion to Methods in Enzymology·Pavel BanásMichal Otyepka
May 16, 2009·Proceedings of the Japan Academy. Series B, Physical and Biological Sciences·Keiji Morokuma
Aug 28, 2009·The Journal of Physical Chemistry. B·Yunxiang LuWeiliang Zhu
Mar 30, 2010·Journal of Medicinal Chemistry·Caterina BissantzMartin Stahl
Apr 20, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J Peter Cegielski
Aug 9, 2011·Current Opinion in Microbiology·Stewart T Cole, Giovanna Riccardi
Aug 24, 2011·Antimicrobial Agents and Chemotherapy·Krisztina M Papp-WallaceRobert A Bonomo
Sep 17, 2011·Journal of Chemical Information and Modeling·Roman A Laskowski, Mark B Swindells
May 23, 2012·Antimicrobial Agents and Chemotherapy·Vincent DubéeMichel Arthur
Mar 23, 2013·Acta Crystallographica. Section D, Biological Crystallography·Dominic BöthGunter Schneider
Sep 1, 1996·Accounts of Chemical Research·G R Desiraju
Sep 4, 2013·Acta Crystallographica. Section D, Biological Crystallography·Stefania CorrealeRita Berisio
Apr 19, 2015·Journal of Biomedical Science·Bahareh HonarparvarHendrik G Kruger
Sep 8, 2009·Journal of Chemical Theory and Computation·M J Harvey, G De Fabritiis
May 1, 2006·Journal of Chemical Theory and Computation·Thom VrevenMichael J Frisch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.